Notice Number: NOT-NS-18-081
Key Dates
Release Date: August 8, 2018
PAR-18-534
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-18-534 "Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Optional)" has been extended by 1 receipt cycle. The new receipt date will be February 15, 2019. The new expiration date will be May 8, 2019.
Par 1. Overview Information
Key Dates
Currently Reads:
| Application Due Date(s) | February 15, 2018; August 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | June 2018, November 2018 |
| Advisory Council Review | October 2018, January 2019 |
| Earliest Start Date | December 2018, April 2019 |
| Expiration Date | August 18, 2018 |
Modified to Read:
| Application Due Date(s) | February 15, 2018; August 17, 2018, February 15, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | June 2018, November 2018, June 2019 |
| Advisory Council Review | October 2018, January 2019, October 2019 |
| Earliest Start Date | December 2018, April 2019, December 2019 |
| Expiration Date | May 8, 2019 |
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Glen H. Nuckolls, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5745
Email: [email protected]
and Human Services (HHS)
